İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2017

The relationship between cognitive impairment in schizophrenia and metabolic syndrome: a systematic review and meta-analysis

Dergi

Psychological Medicine

ISSN 0033-2917

YÖKSİS OpenAlex SJR Q1 JCR Q1 Atıf 225 Üst %10 Yüzdelik 90.5% FWCI 2.64
Yıl
2017
Tür
review

Veri kaynağı ayrımı

  • YÖKSİS YÖKSİS makale kaydı
  • YÖKSİS dergi adı Psychological Medicine
  • Katalog eşleşmesi (ISSN) Psychological Medicine
  • OpenAlex OpenAlex zenginleştirmesi (özet, atıf, konular)

Özet

OpenAlex · İngilizce

BACKGROUND: Individuals with schizophrenia are at greater risk for metabolic syndrome (MetS) which is associated with cognitive deficits in the general population. MetS might be potentially an important contributing factor to cognitive impairment in schizophrenia. METHOD: In the current systematic review and meta-analysis, the findings of 18 studies investigating the association between MetS (and its components) with cognitive impairment in schizophrenia are reviewed. RESULTS: Co-morbidity of MetS (d = 0.28) and diabetes mellitus (d = 0.28) were both associated with more severe cognitive deficits in schizophrenia. There was also evidence for a significant relationship between cognitive impairment in schizophrenia and each of the components of MetS including hypertension, dyslipidemia, abdominal obesity and diabetes. CONCLUSIONS: MetS is significantly associated with cognitive impairment in schizophrenia and can potentially contribute to functional decline observed in some patients with schizophrenia throughout the course of illness.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

225 atıf

OpenAlex cited_by_count (önbellek / veritabanı)

Yazarlar

  1. İBRAHİM EMRE BORA DOKUZ EYLÜL ÜNİVERSİTESİ
  2. BERNA BİNNUR AKDEDE DOKUZ EYLÜL ÜNİVERSİTESİ
  3. KÖKSAL ALPTEKİN DOKUZ EYLÜL ÜNİVERSİTESİ